AR gait training for Parkinson's (NCT06598878)
Reduce freezing episodes while walking
- Trial ID
- NCT06598878
- Official Title
- Effect of AR Environment Stimulation on Proactive and Reactive Modulation of Gait in Individuals With Parkinson Disease
- Goal
- Reduce freezing episodes while walking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Chang Gung University
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- PD - Parkinson's Disease
- Interventions
- AR gait training
Summary For Families
The goal is to see whether augmented reality stimulation can help people with Parkinson's improve proactive planning and rapid reactive adjustments while walking, which could reduce freezing and trips. The approach uses AR gait training that overlays visual cues and simulated obstacles in real time to prompt better step timing, stride length, and quick corrective steps, as a non-drug therapy meant to complement existing treatments like levodopa. Adults 20 years and older with a clinical diagnosis of Parkinson's can join, but people with leg musculoskeletal injuries, osteoporosis, or other peripheral or central nervous system diseases are excluded.
Locations
- Chang Gung University, Taoyuan, Taiwan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying AR gait training. The goal is to see whether augmented reality stimulation can help people with Parkinson's improve proactive planning and rapid reactive adjustments while walking, which could reduce freezing and trips. The approach uses AR gait training that overlays visual cues and simulated obstacles in real time to prompt better step timing, stride length, and quick corrective steps, as a non-drug therapy meant to complement existing treatments like levodopa. Adults 20 years and older with a clinical diagnosis of Parkinson's can join, but people with leg musculoskeletal injuries, osteoporosis, or other peripheral or central nervous system diseases are excluded.
- Who can participate?
- Participants must be at least 20 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.